These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5490655)

  • 1. Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction.
    Gordon RD; Geddes RA; Pawsey CG; O'Halloran MW
    Australas Ann Med; 1970 Nov; 19(4):287-94. PubMed ID: 5490655
    [No Abstract]   [Full Text] [Related]  

  • 2. Amiloride. A potassium-sparing natriuretic agent.
    Bull MB; Laragh JH
    Circulation; 1968 Jan; 37(1):45-53. PubMed ID: 5634728
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissociation of the renin-aldosterone system and refractoriness to the sodium-retaining action of mineralocorticoid during starvation in man.
    Boulter PR; Spark RF; Arky RA
    J Clin Endocrinol Metab; 1974 Feb; 38(2):248-54. PubMed ID: 4812620
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of potassium chloride on plasma renin activity and plasma aldosterone during sodium restriction in normal man.
    Bauer JH; Gauntner WC
    Kidney Int; 1979 Mar; 15(3):286-93. PubMed ID: 513492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hypertension--further sodium and potassium studies.
    Priddle WW; Liu SF; Breithaupt DJ
    J Am Geriatr Soc; 1970 Nov; 18(11):861-92. PubMed ID: 5471845
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertension and hyperkalaemia responding to bendrofluazide.
    Lee MR; Ball SG; Thomas TH; Morgan DB
    Q J Med; 1979 Apr; 48(190):245-58. PubMed ID: 504550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spironolactone as a nonspecific treatment for primary aldosteronism.
    Bravo EL; Dustan HP; Tarazi RC
    Circulation; 1973 Sep; 48(3):491-8. PubMed ID: 4726231
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical correction in the syndrome of hypertension and hyperkalaemia by severe dietary salt restriction suggests renin-aldosterone suppression critical in pathophysiology.
    Klemm SA; Gordon RD; Tunny TJ; Finn WL
    Clin Exp Pharmacol Physiol; 1990 Mar; 17(3):191-5. PubMed ID: 2187635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial potassium loss and hypokalaemia during chlorthalidone administration in patients with essential hypertension: the influence of dietary sodium restriction.
    Landmann-Suter R; Struyvenberg A
    Eur J Clin Invest; 1978 Jun; 8(3):155-64. PubMed ID: 28952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
    Uchida K; Morimoto S; Takeda R; Murakami M
    Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of renin and aldosterone in hypertension due to a renin-secreting tumor.
    Schambelan M; Howes EL; Noakes CA; Biglieri EG
    Am J Med; 1973 Jul; 55(1):86-92. PubMed ID: 4715934
    [No Abstract]   [Full Text] [Related]  

  • 12. Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone.
    Vaughan ED; Laragh JH; Gavras I; Bühler FR; Gavras H; Brunner HR; Baer L
    Am J Cardiol; 1973 Sep; 32(4):523-32. PubMed ID: 4729722
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood pressure and its regulation in spontaneously hypertensive rats bred on the lowest sodium diet for normal growth.
    Takishita S; Fukiyama K; Eto T; Kawazoe N; Kimura Y; Tomita Y; Tsumagari T; Onishi K
    Hypertension; 1996 Jan; 27(1):90-5. PubMed ID: 8591895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired renin responsiveness with secondary hypoaldosteronism.
    Gossain VV; Ferrara EV; Werk EE; Srivastava L; Privitera PJ; Hanenson I
    Arch Intern Med; 1973 Dec; 132(6):885-90. PubMed ID: 4757261
    [No Abstract]   [Full Text] [Related]  

  • 15. Renin subgroups in essential hypertension. Further analysis of their pathophysiological and epidemiological characteristics.
    Brunner HR; Sealey JE; Laragh JH
    Circ Res; 1973 May; 32():Suppl 1:99-105. PubMed ID: 4712516
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of renal tubular acidosis with an abnormally high plasma renin activity.
    Yamaguchi H; Fujii J; Kurihara H; Kimura K; Ikeda M
    Jpn Circ J; 1969 Jan; 33(1):69-72. PubMed ID: 5819026
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of prolonged intravenous infusion of aldosterone in a normal human subject.
    Dawborn JK
    Med J Aust; 1969 May; 1(21):1079-83. PubMed ID: 5792705
    [No Abstract]   [Full Text] [Related]  

  • 18. Incomplete renal tubular acidosis. Physiologic studies in three patients with a defect in lowering urine pH.
    Buckalew VM; McCurdy DK; Ludwig GD; Chaykin LB; Elkinton JR
    Am J Med; 1968 Jul; 45(1):32-42. PubMed ID: 5658867
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of aldosterone on sodium, water and potassium metabolism in chronic renal disease.
    Schrier RW; Regal EM
    Kidney Int; 1972 Mar; 1(3):156-68. PubMed ID: 4671219
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucose-induced paradoxical hyperkalemia in patients with suppression of the renin-aldosterone system: prevention by sodium depletion.
    Radó JP
    J Endocrinol Invest; 1979; 2(4):401-6. PubMed ID: 395185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.